Morningstar® Stock Report™

Regeneron Pharmaceuticals Inc REGN

Flujo de Caja
20192020202120222023
Operating Cash Flow Growth-YOY10.707.74170.47-29.18-8.39
Free Cash Flow Growth-YOY10.400.16225.90-47.967.93
Cap Ex as a % of Sales-5.46%-7.23%-3.43%-13.28%-7.06%
Free Cash Flow/Sales25.44%23.58%40.63%27.91%27.96%
Free Cash Flow/Net Income0.950.570.810.780.93
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures